Carlyle Group Makes $4.15B Offer For J&J Unit

NEW BRUNSWICK, N.J. (AP) -- Johnson & Johnson is being offered $4.15 billion by The Carlyle Group for its Ortho-Clinical Diagnostics business.

The New Brunswick, N.J., company has until the end of March to decide whether to accept the offer. Johnson & Johnson executives will discuss the offer Tuesday, when the health giant and consumer products company reports fourth-quarter results. The company said Thursday that it will consult with works councils and trade unions representing that unit's employees before making a decision.

The Ortho-Clinical business makes equipment for screening blood supplies and detecting and diagnosing conditions such as HIV, diabetes and high cholesterol. The company said a year ago that it was exploring alternatives such as a sale or spinoff for that business.

Company shares are up 25 cents, to $95.05, in premarket trading.

More from

GM Predicts Modest Pretax Profit Gain This Year

Va. Manufacturing Research Center Gets New Member

U.S. Wholesale Costs Rise On Gas Prices

Explore more news here.

More in Operations